Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
dermal absorption in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Justification for type of information:
The dermal absorption factor is reported from a regulatory opinion document from the Scientific Committee on Consumer Products (SCCP). The dermal absorption factor considered in this opinion is used to determine the Margin of Safety (MoS) of 4-methylbenzylidene camphor in sunscreens.

Data source

Reference
Reference Type:
review article or handbook
Title:
OPINION ON 4-Methylbenzylidene camphor (4-MBC) (COLIPA no S60)
Author:
Scientific Committee on Consumer Products (SCCP)
Year:
2008
Report date:
2008

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 428 (Skin Absorption: In Vitro Method)
Version / remarks:
1994, draft
Qualifier:
according to guideline
Guideline:
other: COLIPA Guideline for Percutaneous Absorption/Penetration
Version / remarks:
1995
GLP compliance:
not specified
Remarks:
Study is summarised in a regulatory opinion document; full study details are not available

Test material

Constituent 1
Chemical structure
Reference substance name:
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EC Number:
701-394-3
Cas Number:
1782069-81-1
Molecular formula:
C18H22O
IUPAC Name:
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Radiolabelling:
no

Test animals

Species:
pig
Sex:
female

Administration / exposure

Type of coverage:
not specified
Duration of exposure:
24 hours
Doses:
167 to 200 μg test item/cm², corresponding to 4.5 mg formulation/cm² of a 4% test item formulation
No. of animals per group:
8 experiments, performed in triplicate
Details on study design:
SAMPLE COLLECTION
- Skin surface: Gentle scraping with a spatula and/or threefold wiping with cotton wool (corresponds to non-absorbed sample)
- Horny layer: About 15-20 fold stripping with self-adhesive "tesa-film" tape
- Epidermis: Heating of the skin disc (epidermal side for 45 seconds on a 80°C hot plate (Ceram), separation epidermis from dermis with forceps)
- Dermis: 3 punched samples or total dermis
- Receptor fluid: 2 aliquots

ANALYSIS
- Method type(s) for identification: HPLC-DAD
- Limits of detection and quantification: LOD: approximately 0.03 μg/mL, LOQ: approximately 0.1 μg/mL
Details on in vitro test system (if applicable):
SKIN PREPARATION
- Source of skin: Pig
- Type of skin: Unboiled back skin
- Preparative technique: Skin discs (gently dry-shaved surface, diameter 5 cm)
- Thickness of skin: 3-4 mm

PRINCIPLES OF ASSAY
- Diffusion cell: Glass penetration cell
- Receptor fluid: 0.9% sodium chloride, 1% bovine serum albumin and 0.02% gentamycine sulphate in water
- Solubility of test substance in receptor fluid: Receptor fluid suitable for hydrophilic and lipophilic samples
- Test temperature: 32°C

Results and discussion

Signs and symptoms of toxicity:
not specified
Dermal irritation:
not specified
Absorption in different matrices:
No test item was detected in the receptor fluid.
Total recovery:
Mean total recovery was 91.8% (range 86.8 to 95.6%).
Percutaneous absorption
Key result
Time point:
24 h
Dose:
178 μg/cm²
Parameter:
percentage
Remarks:
1.96 μg/cm² (epidermis+dermis)
Absorption:
1.1 %
Remarks on result:
other: mean of 8 experiments

Any other information on results incl. tables

Table 1. Summary of dermal absorption rates

 Test  Applied substance (μg/cm²)  Surface (μg/cm²)  Horny layer (μg/cm²)  Epidermis (μg/cm²)  Dermis (μg/cm²)  Recovery (%)
 1  182  125  38.2  2.0  0.34  90.9
 2  200  159  26.2  1.3  0.50  93.8
 3  172  132  27.6  2.4  0.72  94.7
 4  175  119  31.0  1.7  0.90  87.2
 5  171  138  23.5  0.7  0.34  95.0
 6  167  132  16.2  1.4  0.88  90.0
 7  187  144  17.1  0.4  not detectable  86.8
 8  173  140  23.5  2.2  not detectable  95.6
 Mean  178  136  25.4  1.5  0.46  91.8
 Standard deviation  11  12.5  7.2  0.7  0.36  3.5

Applicant's summary and conclusion

Conclusions:
Taking into account the values obtained in eight separate experiments, the SCCP consider a mean dermal absorption value of 1.96 μg/cm² as the basis to determine safe use for 4-methylbenzylidene camphor in sunscreen formulations. Based on a mean applied amount of 178 μg/cm², the dermal absorption factor is calculated to be 1.10% (epidermis+dermis).
Executive summary:

Data on the dermal absorption of 4 -methylbenzylidene camphor is available in a regulatory opinion document from the Scientific Committee on Consumer Products (SCCP). Taking into account the values obtained in eight separate in vitro experiments using pig skin, the SCCP consider a mean dermal absorption value of 1.96 μg/cm² as the basis to determine safe use for 4-methylbenzylidene camphor in sunscreen formulations. Based on a mean applied amount of 178 μg/cm², the dermal absorption factor is calculated to be 1.10% (epidermis+dermis). The reliability of this data source cannot be assigned (Klimisch 4) as it is a secondary source reporting from a summary of eight individual experiments. The original studies were not obtained for reliability and relevance assessment, however as the data is used in a regulatory opinion, it is assumed to be sufficiently reliable.